🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#1AI (#ASX #asxnews) media article in The Age Newspaper. Algorae harnessing #AI to meet acute medical needs. Dementia combo drug testing shows promise for Algorae. theage.com.au/business/compa…

Algorae Pharmaceuticals (#ASX Code #1AI) is delighted to launch the AlgoraeOS #ArtificialIntelligence drug discovery and development platform - the only one of its kind in Australia on ASX. #asxnews #ausbiz #ai Click here for presentation: announcements.asx.com.au/asxpdf/2024092…

Algorae AI platform launch set to spark new drug discoveries #ASX #1AI #AI brisbanetimes.com.au/business/compa…

Algorae Pharmaceuticals (#ASX: #1AI) launches AI-powered platform to generate novel drug candidates smallcaps.com.au/algorae-pharma… Algorae Pharmaceuticals

Algorae’s Artificial Intelligence platform launch set to spark new drug discoveries (#ASX code #1AI) smh.com.au/business/compa…

Algorae Pharmaceuticals (#ASX Code: #1AI) #ASXnews: Algorae September 2024 Quarterly Activities Report and Appendix 4C Cash Flow Statement. #CBD #AI #dementia #cardiovascular #biotech #FDA Read here: cdn-api.markitdigital.com/apiman-gateway…

Algorae Pharmaceuticals (#ASX Code #1AI) AI-enabled drug discovery platform identifies 24 wholly owned AI-generated drug targets, significantly expanding Algorae's therapeutic pipeline. #asxnews #ausbiz #artificialintelligence Read here: stocknessmonster.com/announcements/…

Algorae Pharmaceuticals (#ASX: #1AI) to study 24 new drug targets generated by AlgoraeOS AI platform smallcaps.com.au/algorae-pharma… Algorae Pharmaceuticals

Algorae (#ASX code: #1AI) article from Sydney Morning Herald: Algorae taps #AI to develop anti-#cancer drug combos smh.com.au/business/compa…

Algorae Pharmaceuticals (#ASX Code #1AI) appoints pharmaceutical executive Dr Sarah Siggins to the scientific advisory board to provide strategic advice over potential commercial partnerships. Read here: stocknessmonster.com/announcements/… #asxnews #ausbiz #ArtificialIntelligence

Algorae Pharmaceuticals (#ASX: #1AI) strengthens advisory board with appointment of Dr Sarah Siggins smallcaps.com.au/algorae-pharma… Algorae Pharmaceuticals

Algorae’s (#ASX code #1AI) preclinical assessment of drug candidate AI-168 demonstrates statistically significant cardioprotective qualities - outperforming existing first line FDA-approved beta blockers in three cardiovascular cell lines. Read here: stocknessmonster.com/announcements/…

Algorae Pharma’s (#ASX: #1AI) drug AI-168 shows cardioprotection, outperforms beta blockers in pre-clinical studies of proliferation smallcaps.com.au/algorae-pharma… Algorae Pharmaceuticals

Algorae Pharmaceuticals (#ASX Code: #1AI) #ASXnews: Algorae December 2024 Quarterly Activities Report and Appendix 4C Cash Flow Statement. #CBD #AI #dementia #cardiovascular #biotech #FDA Read here: stocknessmonster.com/announcements/…

Algorae Pharmaceuticals (#ASX: #1AI) #ASXNews: Algorae Receives A$451,359 R&D Cash Rebate to be allocated to R&D and the pursuit of early revenue opportunities, where feasible. Read here: stocknessmonster.com/announcements/…

Algorae Pharmaceuticals (#ASX: #1AI) #ASXNews: Algorae Strengthens Leadership Team with Appointment of Vishal Shah as Chief Commercial Officer. Read here: stocknessmonster.com/announcements/…

I’m thrilled to announce the appointment of Vishal Shah as our Chief Commercial Officer. Algorae will continue to focus on recruiting the best talent in Australia to execute our corporate strategy. Thank you to our loyal shareholder base. #1AI Algorae Pharmaceuticals

Algorae Pharmaceuticals (#ASX Code: #1AI) #ASXnews: Algorae March 2025 Quarterly Activities Report and Appendix 4C Cash Flow Statement. #CBD #AI #dementia #cardiovascular #biotech #FDA Read here: stocknessmonster.com/announcements/…

Algorae (#ASX #1AI) announces that it has partnered with the prestigious Peter Macallum Cancer Centre to evaluate 24 wholly owned drug targets, 21 of which were generated by the AlgoraeOS #ArtificialIntelligence drug discovery platform. Read more here: stocknessmonster.com/announcements/…

Algorae Pharmaceuticals (#ASX Code: #1AI) Receives A$318,771 R&D Cash Rebate from ATO. Read here: stocknessmonster.com/announcements/…